Carisma Therapeutics, Inc.
CARM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$60 | -$87 | -$61 | -$41 |
| Dep. & Amort. | $3 | $3 | $6 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $2 | $0 | $0 |
| Change in WC | -$12 | -$5 | $45 | $1 |
| Other Non-Cash | $6 | $6 | $2 | $1 |
| Operating Cash Flow | -$60 | -$81 | -$8 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$5 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$34 | -$91 | $0 |
| Inv. Sales/Matur. | $0 | $108 | $63 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $72 | -$33 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | $0 |
| Stock Issued | $2 | $31 | $35 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $32 | $2 | $16 |
| Financing Cash Flow | $0 | $62 | $36 | $16 |
| Forex Effect | $0 | $0 | -$134 | $0 |
| Net Chg. in Cash | -$60 | $53 | -$138 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78 | $24 | $163 | $52 |
| End Cash | $18 | $78 | $24 | $29 |
| Free Cash Flow | -$60 | -$82 | -$12 | -$39 |